Promising therapeutic approach for improving mitochondrial function
Scientists have made progress in the development of products that improve mitochondrial function...
List view / Grid view
Scientists have made progress in the development of products that improve mitochondrial function...
25 May 2016 | By Victoria White, Digital Content Producer
Thunderbolt is the first company established by Vitesse Biologics, a unique collaboration model formed by Baxalta, Mayo Clinic and VPD...
1 April 2016 | By Victoria White
Astellas and AIST aim to discover new drugs using genome editing technology and a high throughput activity assay for Trypanosoma cruzi...
1 February 2016 | By Victoria White
Astellas and CLINO have entered into a license agreement for the worldwide development and commercialisation of Adeno-associated Virus-modified Volvox channelrhodopsin-1 (AAV-mVChR1)...
14 December 2015 | By Victoria White
Bellicum has been granted rights to develop and commercialise adoptive cell therapies for tumours expressing Prostate Stem Cell Antigen (PSCA) using PCSA technology in-licensed and developed at Agensys...
26 October 2015 | By Victoria White
NVC has already initiated research collaborations with two partners to develop a nosocomial vaccine...
2 June 2015 | By Victoria White
Astellas Pharma and Anokion are to collaborate in the fields of type 1 diabetes and coeliac disease by establishing new drug discovery company Kanyos Bio...
22 April 2015 | By Victoria White
Astellas and Potenza have entered an exclusive R&D collaboration. The agreement includes an option for the future acquisition of Potenza by Astellas...
19 March 2014 | By Daiichi Sankyo
Astellas Pharma Inc. and Daiichi Sankyo Company, Limited announced the companies would form a compound library sharing partnership for approximately 400,000 selected compounds...